Home » Biovail Enters Into License and Development Agreement
Biovail Enters Into License and Development Agreement
Biovail Corporation announced that a subsidiary, Biovail Laboratories International SRL, has entered into a license and development agreement with an undisclosed, privately held, drug-development company for the exclusive global rights to BVF-324, a novel product for the treatment of a prevalent sexual dysfunction.
Biovail
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May